These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 31556570)

  • 1. Risk factors for Alzheimer's disease.
    A Armstrong R
    Folia Neuropathol; 2019; 57(2):87-105. PubMed ID: 31556570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What causes alzheimer's disease?
    Armstrong RA
    Folia Neuropathol; 2013; 51(3):169-88. PubMed ID: 24114635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laminar distribution of β-amyloid (Aβ) peptide deposits in the frontal lobe in familial and sporadic Alzheimer's disease.
    Armstrong RA
    Folia Neuropathol; 2015; 53(1):15-23. PubMed ID: 25909871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism.
    Gandy S; Petanceska S
    Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New frontiers in Alzheimer's disease genetics.
    Tanzi RE; Bertram L
    Neuron; 2001 Oct; 32(2):181-4. PubMed ID: 11683989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetics of Alzheimer's disease.
    Goate AM
    Geriatrics; 1997 Sep; 52 Suppl 2():S9-12. PubMed ID: 9307578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
    Xu BG; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease.
    Thaker U; McDonagh AM; Iwatsubo T; Lendon CL; Pickering-Brown SM; Mann DM
    Neuropathol Appl Neurobiol; 2003 Feb; 29(1):35-44. PubMed ID: 12581338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors for Alzheimer's disease].
    Ikeda T; Yamada M
    Brain Nerve; 2010 Jul; 62(7):679-90. PubMed ID: 20675872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic factors and a polygenic model of Alzheimer's disease].
    Rogaev EI
    Genetika; 1999 Nov; 35(11):1558-71. PubMed ID: 10624576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
    Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
    Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic complexity of Alzheimer's disease: successes and challenges.
    Rogaeva E; Kawarai T; George-Hyslop PS
    J Alzheimers Dis; 2006; 9(3 Suppl):381-7. PubMed ID: 16914876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate gene association studies in sporadic Alzheimer's disease.
    Combarros O; Alvarez-Arcaya A; Sánchez-Guerra M; Infante J; Berciano J
    Dement Geriatr Cogn Disord; 2002; 14(1):41-54. PubMed ID: 12053131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the etiology of Alzheimer disease using molecular genetics.
    Lendon CL; Ashall F; Goate AM
    JAMA; 1997 Mar; 277(10):825-31. PubMed ID: 9052714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of causative genes and genetic risk factor in Alzheimer's disease].
    Urakami K; Wakutani Y; Wada-Isoe K; Yamagata K; Adachi Y; Nakashima K
    Nihon Ronen Igakkai Zasshi; 2001 Nov; 38(6):769-71. PubMed ID: 11774719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain.
    Lleó A; Blesa R; Queralt R; Ezquerra M; Molinuevo JL; Peña-Casanova J; Rojo A; Oliva R
    Arch Neurol; 2002 Nov; 59(11):1759-63. PubMed ID: 12433263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.
    Jayne T; Newman M; Verdile G; Sutherland G; Münch G; Musgrave I; Moussavi Nik SH; Lardelli M
    J Alzheimers Dis; 2016 Apr; 52(3):781-99. PubMed ID: 27060961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.